332 related articles for article (PubMed ID: 24075941)
1. LRRK2 guides the actin cytoskeleton at growth cones together with ARHGEF7 and Tropomyosin 4.
Häbig K; Gellhaar S; Heim B; Djuric V; Giesert F; Wurst W; Walter C; Hentrich T; Riess O; Bonin M
Biochim Biophys Acta; 2013 Dec; 1832(12):2352-67. PubMed ID: 24075941
[TBL] [Abstract][Full Text] [Related]
2. ARHGEF7 (Beta-PIX) acts as guanine nucleotide exchange factor for leucine-rich repeat kinase 2.
Haebig K; Gloeckner CJ; Miralles MG; Gillardon F; Schulte C; Riess O; Ueffing M; Biskup S; Bonin M
PLoS One; 2010 Oct; 5(10):e13762. PubMed ID: 21048939
[TBL] [Abstract][Full Text] [Related]
3. Tropomyosins induce neuritogenesis and determine neurite branching patterns in B35 neuroblastoma cells.
Curthoys NM; Freittag H; Connor A; Desouza M; Brettle M; Poljak A; Hall A; Hardeman E; Schevzov G; Gunning PW; Fath T
Mol Cell Neurosci; 2014 Jan; 58():11-21. PubMed ID: 24211701
[TBL] [Abstract][Full Text] [Related]
4. Phosphorylation of LRRK2 by casein kinase 1α regulates trans-Golgi clustering via differential interaction with ARHGEF7.
Chia R; Haddock S; Beilina A; Rudenko IN; Mamais A; Kaganovich A; Li Y; Kumaran R; Nalls MA; Cookson MR
Nat Commun; 2014 Dec; 5():5827. PubMed ID: 25500533
[TBL] [Abstract][Full Text] [Related]
5. A QUICK screen for Lrrk2 interaction partners--leucine-rich repeat kinase 2 is involved in actin cytoskeleton dynamics.
Meixner A; Boldt K; Van Troys M; Askenazi M; Gloeckner CJ; Bauer M; Marto JA; Ampe C; Kinkl N; Ueffing M
Mol Cell Proteomics; 2011 Jan; 10(1):M110.001172. PubMed ID: 20876399
[TBL] [Abstract][Full Text] [Related]
6. Leucine-rich repeat kinase 2 interacts with p21-activated kinase 6 to control neurite complexity in mammalian brain.
Civiero L; Cirnaru MD; Beilina A; Rodella U; Russo I; Belluzzi E; Lobbestael E; Reyniers L; Hondhamuni G; Lewis PA; Van den Haute C; Baekelandt V; Bandopadhyay R; Bubacco L; Piccoli G; Cookson MR; Taymans JM; Greggio E
J Neurochem; 2015 Dec; 135(6):1242-56. PubMed ID: 26375402
[TBL] [Abstract][Full Text] [Related]
7. βPix-d promotes tubulin acetylation and neurite outgrowth through a PAK/Stathmin1 signaling pathway.
Kwon Y; Jeon YW; Kwon M; Cho Y; Park D; Shin JE
PLoS One; 2020; 15(4):e0230814. PubMed ID: 32251425
[TBL] [Abstract][Full Text] [Related]
8. Phosphorylation of ezrin/radixin/moesin proteins by LRRK2 promotes the rearrangement of actin cytoskeleton in neuronal morphogenesis.
Parisiadou L; Xie C; Cho HJ; Lin X; Gu XL; Long CX; Lobbestael E; Baekelandt V; Taymans JM; Sun L; Cai H
J Neurosci; 2009 Nov; 29(44):13971-80. PubMed ID: 19890007
[TBL] [Abstract][Full Text] [Related]
9. Deletion of the Actin-Associated Tropomyosin
Tomanić T; Martin C; Stefen H; Parić E; Gunning P; Fath T
Cells; 2021 Mar; 10(3):. PubMed ID: 33807093
[TBL] [Abstract][Full Text] [Related]
10. Rac1 protein rescues neurite retraction caused by G2019S leucine-rich repeat kinase 2 (LRRK2).
Chan D; Citro A; Cordy JM; Shen GC; Wolozin B
J Biol Chem; 2011 May; 286(18):16140-9. PubMed ID: 21454543
[TBL] [Abstract][Full Text] [Related]
11. Leucine-rich repeat kinase 2 regulates tau phosphorylation through direct activation of glycogen synthase kinase-3β.
Kawakami F; Shimada N; Ohta E; Kagiya G; Kawashima R; Maekawa T; Maruyama H; Ichikawa T
FEBS J; 2014 Jan; 281(1):3-13. PubMed ID: 24165324
[TBL] [Abstract][Full Text] [Related]
12. Functional interaction of Parkinson's disease-associated LRRK2 with members of the dynamin GTPase superfamily.
Stafa K; Tsika E; Moser R; Musso A; Glauser L; Jones A; Biskup S; Xiong Y; Bandopadhyay R; Dawson VL; Dawson TM; Moore DJ
Hum Mol Genet; 2014 Apr; 23(8):2055-77. PubMed ID: 24282027
[TBL] [Abstract][Full Text] [Related]
13. 14-3-3 Proteins regulate mutant LRRK2 kinase activity and neurite shortening.
Lavalley NJ; Slone SR; Ding H; West AB; Yacoubian TA
Hum Mol Genet; 2016 Jan; 25(1):109-22. PubMed ID: 26546614
[TBL] [Abstract][Full Text] [Related]
14. A novel FERM domain including guanine nucleotide exchange factor is involved in Rac signaling and regulates neurite remodeling.
Kubo T; Yamashita T; Yamaguchi A; Sumimoto H; Hosokawa K; Tohyama M
J Neurosci; 2002 Oct; 22(19):8504-13. PubMed ID: 12351724
[TBL] [Abstract][Full Text] [Related]
15. Phosphoproteomic evaluation of pharmacological inhibition of leucine-rich repeat kinase 2 reveals significant off-target effects of LRRK-2-IN-1.
Luerman GC; Nguyen C; Samaroo H; Loos P; Xi H; Hurtado-Lorenzo A; Needle E; Stephen Noell G; Galatsis P; Dunlop J; Geoghegan KF; Hirst WD
J Neurochem; 2014 Feb; 128(4):561-76. PubMed ID: 24117733
[TBL] [Abstract][Full Text] [Related]
16. No dopamine cell loss or changes in cytoskeleton function in transgenic mice expressing physiological levels of wild type or G2019S mutant LRRK2 and in human fibroblasts.
Garcia-Miralles M; Coomaraswamy J; Häbig K; Herzig MC; Funk N; Gillardon F; Maisel M; Jucker M; Gasser T; Galter D; Biskup S
PLoS One; 2015; 10(4):e0118947. PubMed ID: 25830304
[TBL] [Abstract][Full Text] [Related]
17. GEFT, a Rho family guanine nucleotide exchange factor, regulates neurite outgrowth and dendritic spine formation.
Bryan B; Kumar V; Stafford LJ; Cai Y; Wu G; Liu M
J Biol Chem; 2004 Oct; 279(44):45824-32. PubMed ID: 15322108
[TBL] [Abstract][Full Text] [Related]
18. A comparative study of Lrrk2 function in primary neuronal cultures.
Dächsel JC; Behrouz B; Yue M; Beevers JE; Melrose HL; Farrer MJ
Parkinsonism Relat Disord; 2010 Dec; 16(10):650-5. PubMed ID: 20850369
[TBL] [Abstract][Full Text] [Related]
19. RNA interference of LRRK2-microarray expression analysis of a Parkinson's disease key player.
Häbig K; Walter M; Poths S; Riess O; Bonin M
Neurogenetics; 2008 May; 9(2):83-94. PubMed ID: 18097693
[TBL] [Abstract][Full Text] [Related]
20. Distinct functions of Trio GEF domains in axon outgrowth of cerebellar granule neurons.
Tao T; Sun J; Peng Y; Wang P; Chen X; Zhao W; Li Y; Wei L; Wang W; Zheng Y; Wang Y; Zhang X; Zhu MS
J Genet Genomics; 2019 Feb; 46(2):87-96. PubMed ID: 30850274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
